| 31st Oct 2018 12:02 pm |
RNS |
Price Monitoring Extension |
| 31st Oct 2018 12:00 pm |
RNS |
3rd Quarter Results |
| 30th Oct 2018 2:30 pm |
RNS |
ViiV: positive data for long-acting injectable |
| 29th Oct 2018 10:00 am |
RNS |
ViiV - three-year data for long-acting injectable |
| 18th Oct 2018 4:00 pm |
RNS |
ViiV submits HIV 2DR regulatory application to FDA |
| 18th Oct 2018 9:34 am |
RNS |
Director/PDMR Shareholding |
| 17th Oct 2018 5:56 pm |
RNS |
Director/PDMR Shareholding |
| 17th Oct 2018 5:50 pm |
RNS |
Director/PDMR Shareholding |
| 17th Oct 2018 11:30 am |
RNS |
Director/PDMR Shareholding |
| 16th Oct 2018 4:53 pm |
RNS |
Director/PDMR Shareholding |
| 16th Oct 2018 9:30 am |
RNS |
Director/PDMR Shareholding |
| 16th Oct 2018 9:30 am |
RNS |
Director/PDMR Shareholding |
| 10th Oct 2018 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 1st Oct 2018 1:58 pm |
RNS |
Total Voting Rights |
| 27th Sep 2018 4:35 pm |
RNS |
Director/PDMR Shareholding |
| 21st Sep 2018 12:30 pm |
RNS |
CHMP recommends expansion of Trelegy COPD label |
| 14th Sep 2018 9:00 am |
RNS |
ViiV submits HIV 2DR regulatory application to EMA |
| 12th Sep 2018 5:43 pm |
RNS |
Director/PDMR Shareholding |
| 10th Sep 2018 8:00 am |
RNS |
New analysis on efficacy of anti-IL5 biologics SEA |
| 10th Sep 2018 7:00 am |
RNS |
GSK receives CRL from FDA for mepolizumab in COPD |
| 7th Sep 2018 2:24 pm |
RNS |
Director/PDMR Shareholding |
| 7th Sep 2018 2:18 pm |
RNS |
Director/PDMR Shareholding |
| 3rd Sep 2018 5:00 pm |
RNS |
Total Voting Rights |
| 30th Aug 2018 5:12 pm |
RNS |
GSK publishes Q4 2018 Dividend Dates |
| 30th Aug 2018 8:12 am |
RNS |
EU approve Nucala in severe asthma in children |
| 24th Aug 2018 10:16 am |
RNS |
Director/PDMR Shareholding |
| 15th Aug 2018 7:00 am |
RNS |
Positive headline results for ViiV HC ATLAS study |
| 10th Aug 2018 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 8th Aug 2018 12:35 pm |
RNS |
Director/PDMR Shareholding |
| 7th Aug 2018 7:00 am |
RNS |
Iain Mackay appointed GSK Chief Financial Officer |
| 2nd Aug 2018 5:07 pm |
RNS |
Publication of Base Prospectus |
| 2nd Aug 2018 11:04 am |
RNS |
Total Voting Rights |
| 31st Jul 2018 5:03 pm |
RNS |
Director/PDMR Shareholding |
| 31st Jul 2018 4:37 pm |
RNS |
Director/PDMR Shareholding |
| 27th Jul 2018 4:30 pm |
RNS |
Director/PDMR Shareholding |
| 27th Jul 2018 2:47 pm |
RNS |
CHMP recommend Nucala for severe asthma children |
| 26th Jul 2018 7:00 am |
RNS |
GSK reports on FDA Ad Com on mepolizumab for COPD |
| 25th Jul 2018 4:15 pm |
RNS |
Director/PDMR Shareholding |
| 25th Jul 2018 11:00 am |
RNS |
GSK and 23andMe Agreement |
| 25th Jul 2018 11:00 am |
RNS |
2nd Quarter Results |
